Garabano German, Jaime Adrian, Juri Andres, Pesciallo Cesar, Giannoudis Peter V
Hospital Británico de Buenos Aires, Buenos Aires, Argentina.
University of Leeds, Leeds, United Kingdom.
Eur J Orthop Surg Traumatol. 2025 Sep 9;35(1):386. doi: 10.1007/s00590-025-04513-z.
This study aimed to evaluate the health perception of quality of life and function in patients with segmental bone defects (SBD) of the femur or tibia treated with the Induced Membrane Technique (IMT) and achieved bone healing and infection control.
This cross-sectional cohort study was conducted at a single referral center. Patients with infected SBD of the femur or tibia treated with IMT were included if they had at least 12 months of bone healing and no evidence of infection. Three questionnaires were administered: the EuroQol five-dimensional questionnaire (EQ-5D), the short form 36 (SF-36), and the lower extremity functional score (LEFS).
The final cohort consisted of 33 patients, with a mean age of 39 ± 16.7 years. Twenty defects involved the tibia. The average bone defect measured 6 cm (range 3.5-12). The median healing time was 7.4 months (range 3-14), with 30 patients (90.9%) achieving healing without reoperation. The average follow-up period from the second stage was 46 months (range 20-85). Questionnaires were completed on average at 30 months (range 15-70) after bone healing was recorded. The mean EQ-5D VAS score was 63.63 ± 13.20, and the EQ-5D index was 0.72 ± 0.26. In the SF-36, the mean MCS was 52.8 ± 3.2, and the PCS was 46.45 ± 3.9. The mean LEFS score was 65 ± 4.8, with a range of 55 to 73. Overall, out of the 5, the EQ-5D mobility and pain/discomfort had the lowest scores, whereas in the LEFS, the items indicating limitations required greater physical demand, such as walking more than a mile, running, and jumping.
Despite successful bone healing and infection control with the IMT, patients with infected femoral or tibial SBD continue to experience an impaired quality of life more than 2 years after treatment. Although functional and mental scores were relatively acceptable, patients reported physical limitations and discomfort with certain tasks, highlighting ongoing challenges in their physical recovery.
本研究旨在评估采用诱导膜技术(IMT)治疗股骨或胫骨节段性骨缺损(SBD)并实现骨愈合和感染控制的患者对生活质量和功能的健康认知。
本横断面队列研究在单一转诊中心进行。纳入采用IMT治疗的股骨或胫骨感染性SBD患者,要求其骨愈合至少12个月且无感染迹象。发放了三份问卷:欧洲五维健康量表(EQ-5D)、简短健康调查问卷(SF-36)和下肢功能评分(LEFS)。
最终队列包括33例患者,平均年龄39±16.7岁。20处缺损累及胫骨。平均骨缺损为6cm(范围3.5 - 12cm)。中位愈合时间为7.4个月(范围3 - 14个月),30例患者(90.9%)实现愈合且无需再次手术。从第二阶段开始的平均随访期为46个月(范围20 - 85个月)。问卷平均在记录骨愈合后30个月(范围15 - 70个月)完成。EQ-5D视觉模拟量表(VAS)平均评分为63.63±13.20,EQ-5D指数为0.72±0.26。在SF-36中,平均精神健康综合评分(MCS)为52.8±3.2,生理健康综合评分(PCS)为46.45±3.9。LEFS平均评分为65±4.8,范围为55至73。总体而言,在五个维度中,EQ-5D的行动能力和疼痛/不适维度得分最低,而在LEFS中,表明需要更大体力要求的项目得分较低,如行走超过一英里、跑步和跳跃。
尽管采用IMT成功实现了骨愈合和感染控制,但股骨或胫骨感染性SBD患者在治疗后两年多仍存在生活质量受损的情况。虽然功能和心理评分相对尚可,但患者报告存在身体限制以及在某些任务中感到不适,这突出了他们身体恢复方面仍面临的挑战。